BodyMedia is focused on providing clinicians and patients with the most accurate and effective tools for the management of metabolic disorders.
- Acquired by Jawbone -
Corhythm is an early stage company developing devices for the treatment of atrial fibrillation.
WhiteSwell Leveraging the Lymphatic System to Treat ADHF
Fe3 is developing a novel approach for the treatment of iron-deficiency anemia.
IntraPace has developed an innovative product platform utilizing gastric stimulation for the treatment of obesity.
Neurolink is an early stage company focused on a novel approach for the treatment of epilepsy.
Nfocus is a neurovascular company focused on treating hemorrhagic stroke with a new technology for rapidly treating aneurysms and fistulas in the brain.
- Acquired by Covidien -
Rani Therapeutics has developed a novel approach for delivering peptides, proteins and antibodies orally.
Sonoma Orthopedics is developing implants for treating and repairing bone fractures.
Spinal Modulation is an early-stage venture creating innovative implantable devices for the management of chronic pain.
- Acquired by St. Jude Medical -
Wellaware is an early-stage venture creating innovative.
VentureHealth is an early-stage venture creating innovative.
Intact developing medical devices for predictive and diagnostic medicine based on a novel platform technology.